A phase III registration trial of venetoclax in patients with acute myeloid leukemia
Phase of Trial: Phase III
Latest Information Update: 29 Jul 2016
At a glance
- Drugs Venetoclax (Primary)
- Indications Acute myeloid leukaemia
- Focus Registrational; Therapeutic Use
- Sponsors AbbVie
- 29 Jul 2016 According to an AbbVie media release, the company plans to start this trial by the end of 2016.
- 03 Feb 2016 New trial record
- 29 Jan 2016 The company plans to initiate this trial in 2016, according to an AbbVie media release.